Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immuneering (IMRX) Other Non-Current Assets (2020 - 2024)

Immuneering has reported Other Non-Current Assets over the past 5 years, most recently at $1.3 million for Q3 2024.

  • Quarterly results put Other Non-Current Assets at $1.3 million for Q3 2024, up 74.23% from a year ago — trailing twelve months through Sep 2024 was $1.3 million (up 74.23% YoY), and the annual figure for FY2023 was $1.0 million, up 39.09%.
  • Other Non-Current Assets for Q3 2024 was $1.3 million at Immuneering, up from $1.2 million in the prior quarter.
  • Over the last five years, Other Non-Current Assets for IMRX hit a ceiling of $1.3 million in Q3 2024 and a floor of $14333.0 in Q4 2020.
  • Median Other Non-Current Assets over the past 5 years was $743703.0 (2022), compared with a mean of $650662.8.
  • Peak annual rise in Other Non-Current Assets hit 5044.02% in 2022, while the deepest fall reached 90.67% in 2022.
  • Immuneering's Other Non-Current Assets stood at $14333.0 in 2020, then surged by 612.54% to $102129.0 in 2021, then skyrocketed by 628.2% to $743703.0 in 2022, then surged by 39.09% to $1.0 million in 2023, then increased by 25.26% to $1.3 million in 2024.
  • The last three reported values for Other Non-Current Assets were $1.3 million (Q3 2024), $1.2 million (Q2 2024), and $1.2 million (Q1 2024) per Business Quant data.